-
Amgen acquisition will help get Cancer drugs into the Chinese market.
#healthcare#investing$HHL https://www.cnbc.com/2019/10/31/amgen-takes-20percent-stake-in-chinese-biotech-beigene-for-2point7-billion.html?__source=iosappshare%7Ccom.apple.UIKit.activity.Mail … -
Hunter Hall founder sells remaining 24pc stake after Soul Patts sweetens bid http://bit.ly/2mpUlm1 by
@Danielbpalmer#ausbiz$HHL -
Amgen bets on growth in China
#healthcare#investing https://harvestportfolios.com/amgen-bets-on-growth-in-china/ … Amgen is a top holding of the Harvest Healthcare Leaders Income ETF$HHL -
$SOL buy 20% of$HHL (last trade $3.10) @ ~70% discount from Peter Hall, launches bid at $1/sh.#takeunder -
Rating Update for Hunter Hall International Ltd
$HHL https://www.sadifanalytics.com/reports/find/HHL-33327 … -
Director buys 125K of
$HHL:ASX giving them a total holding of ~$886K (~1.08% of the company) http://stocklight.com/insiders/ASX:HHL/60121?src=asxinsiders … -
Pinnacle Ethical Investment turns up substantial in
$HHL. Funny Pinnacle's "ethical" brand originated only this yr http://bit.ly/2jxK8r0 -
$AVH/@AvitaMedical:$HHL/Hunter Hall sells 7.5m shares. Trims stake from 17.66% to 16.54%. -
-
$HHL:AU Pengana merger plan lights fire under Hunter Hall shares#HUNTER HALL INTL LTD http://tinyurl.com/hmechja#ASX2000 -
$HHL @HunterHallFunds - Shareholders vote in favour of merger with Pengana Capital |#investment#news#ausbiz http://ow.ly/keE430cdkKP -
$HHL @HunterHallFunds - General meeting – presentation |#Australian#equity#investment#news#ausbiz http://ow.ly/ceeg30cdkpR -
Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment https://www.reuters.com/article/us-china-health-regeneron-pharms/drugmaker-regeneron-working-with-us-hhs-to-develop-coronavirus-treatment-idUSKBN1ZY1SV …
#Healthcare$HHL -
Medtronic in the news for its smallest, lightest pacemaker ... learn more https://harvestportfolios.com/medtronic-pacemaker-smallest-lightest-ever/ …
#healthcare#investments#income$HHL -
Gilead starts Corona Virus human trials after drug shows early promise. https://www.bloomberg.com/news/articles/2020-02-03/gilead-drug-to-undergo-human-trials-in-china-to-cure-coronavirus …
#Gilead is a holding in$HHL.#Healthcare#biotechstock -
took some
$HHL for divy again. May or may not buy the top but i dont care....
Just gonna do dollar-cost averaging each quarter... I'm not gonna be trading too actively lately till August due to school work. -
-
$HHL.TO$HHL weekly downtrend broken. May start a slow reversal now. Nice dividend yield too. pic.twitter.com/bFegyfTJ4W
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.